APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma

SIMPLE SUMMARY: Around 15% of papillary thyroid carcinoma (PTC) patients are not cured using standard surgery followed by radioactive iodine (RAI) therapy, and instead develop refractory disease. The aim of this study was to help identify RAI-refractory PTC patients early and guide precision medicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Siraj, Sarah, Masoodi, Tariq, Siraj, Abdul K., Azam, Saud, Qadri, Zeeshan, Parvathareddy, Sandeep K., Bu, Rong, Siddiqui, Khawar S., Al-Sobhi, Saif S., AlDawish, Mohammed, Al-Kuraya, Khawla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946015/
https://www.ncbi.nlm.nih.gov/pubmed/35326735
http://dx.doi.org/10.3390/cancers14061584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946015/
https://www.ncbi.nlm.nih.gov/pubmed/35326735
http://dx.doi.org/10.3390/cancers14061584

Ejemplares similares